| Market Cap | ₹119Cr |
| ROE | 9.10% |
| P/E Ratio(TTM) | 12.30 |
| EPS(TTM) | 7.87 |
| P/B Ratio | 1.12 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.34 |
| Book Value | 86.50 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Par Drugs & Chemicals Limited |
| Managing Director | Mr. Falgun Savani |
| NSE Symbol | PAR |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.15 | ||
| Neuland Laboratories | NA (0.00%) | 90.31 | ||
| Jubilant Pharmova | NA (0.00%) | 36.15 | ||
| Acutaas Chemicals | NA (0.00%) | 61.94 |